Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
A siderophore hydroxamate moiety is a chemical functional group (C(=O)N(OH)R) found in many microbial siderophores—small molecules secreted to chelate ferric iron (Fe(III)) from the environment.[2][3][5] The hydroxamate group acts as a bidentate ligand, tightly binding Fe(III) with high selectivity. Siderophore hydroxamate moieties are present in various natural products (notably in fungi and bacteria) like ferrichrome, coprogen, and desferrioxamine[3][2]. They enable microbial iron acquisition, crucial for survival under iron-limiting conditions such as during host infection. In medicine, synthetic and natural hydroxamate siderophores (like desferrioxamine) are used as iron chelators, and hydroxamate-containing siderophores are being studied as potential vectors for antimicrobial payloads (Trojan horse antibiotics). The “siderophore hydroxamate moiety” is not itself a therapeutic target in the conventional sense (e.g., it is not a protein, enzyme, or receptor), but a structural component; drug discovery efforts often focus on exploiting microbial utilization of such moieties for selective drug delivery or as chelation agents.[5][2][3]
Chelation of Fe(III) ions; Facilitation of iron transport into microbial cells; Drug delivery (Trojan horse mechanism for antibacterial agents)
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Siderophore hydroxamate moiety.